TG and neoplasm: Initial risk stratification can be very challenging (and probably less accurate) if the serum Tg values cannot be reliably measured (e.g. the presence of interfering anti-Tg antibodies) or if the tumor is a poor Tg producer (poorly differentiated cancers).